Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer (DEMRAC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01774266|
Recruitment Status : Unknown
Verified May 2013 by Pontificia Universidad Catolica de Chile.
Recruitment status was: Recruiting
First Posted : January 23, 2013
Last Update Posted : June 3, 2013
|Condition or disease|
|Early Gastric Cancer|
|Study Type :||Observational|
|Estimated Enrollment :||3000 participants|
|Official Title:||Screening and Triage Test for Early Detection of Gastric Cancer|
|Study Start Date :||September 2012|
|Actual Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||March 2014|
Molina - Chile
Molina is one of the counties with the highest mortality rate of gastric cancer in Chile. Molina has a population of 40.000 hab mostly rural. Half of the population lives in Molina city and the other half in the suburbs. Molina is located near the Mountain Andes.
- Early detection of gastric cancer [ Time Frame: 2 years ]Increase the frequency of early detection rate of gastric cancer
- Monitoring progression of disease [ Time Frame: 2 years ]In the case in which diagnoses of gastric cancer will be made, the result of treatment will be measure
- Detection of H.pylori and gastric atrophy [ Time Frame: 2 years ]The rate of H.pylori detection and gastric atrophy based on serum levels of H.pylori and Pepsinogens I/II ratio.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01774266
|Contact: Alejandro H. Corvalan, M.D.||+email@example.com|
|Hospital Santa Rosa de Molina||Recruiting|
|Molina, Region del Maule, Chile, 8320000|
|Contact: Alejandro Corvalan, M.D. 56223548289 firstname.lastname@example.org|
|Contact: Paz Cook, R.N. 56223548289 email@example.com|
|Principal Investigator: Mauricio Olivera, M.D.|